...
首页> 外文期刊>American Journal of Pathology >T Lymphocytes Induce Endothelial Cell Matrix Metalloproteinase Expression by a CD40L-Dependent Mechanism : Implications for Tubule Formation
【24h】

T Lymphocytes Induce Endothelial Cell Matrix Metalloproteinase Expression by a CD40L-Dependent Mechanism : Implications for Tubule Formation

机译:T淋巴细胞通过CD40L依赖性机制诱导内皮细胞基质金属蛋白酶表达:对肾小管形成的影响

获取原文
获取原文并翻译 | 示例

摘要

Neovascularization frequently accompanies chronic immune responses characterized by T cell infiltration and activation. Angiogenesis requires endothelial cells (ECs) to penetrate extracellular matrix, a process that involves matrix metalloproteinases (MMPs). We report here that activated human T cells mediate contact-dependent expression of MMPs in ECs through CD40/CD40 ligand signaling. Ligation of CD40 on ECs induced de novo expression of gelatinase B (MMP-9), increased interstitial collagenase (MMP-1) and stromelysin (MMP-3), and activated gelatinase A (MMP-2). Recombinant human CD40L induced expression of MMPs by human vascular ECs to a greater extent than did maximally effective concentrations of interleukin-1ß or tumor necrosis factor-. Moreover, activation of human vascular ECs through CD40 induced tube formation in a three-dimensional fibrin matrix gel assay, an effect antagonized by a MMP inhibitor. These results demonstrated that activation of ECs by interaction with T cells induced synthesis and release of MMPs and promoted an angiogenic function of ECs via CD40L-CD40 signaling. As vascular cells at the sites of chronic inflammation, such as atherosclerotic plaques, express CD40 and its ligand, our findings suggest that ligation of CD40 on ECs can mediate aspects of vascular remodeling and neovessel formation during atherogenesis and other chronic immune reactions.
机译:新血管形成经常伴随以T细胞浸润和激活为特征的慢性免疫反应。血管生成需要 内皮细胞(EC)穿透细胞外基质,这是一个涉及基质金属蛋白酶(MMP)的 过程。我们在这里报告 ,活化的人类T细胞通过CD40 / CD40配体信号传导介导EC中MMP的接触依赖性表达。 CD40对EC的连接诱导的明胶酶 B(MMP-9)从头表达,间质胶原酶(MMP-1)和基质溶菌素 (MMP-3)增加以及活化的明胶酶A(MMP- 2)。重组人 CD40L诱导人血管EC产生MMPs的程度比最大有效浓度的 interleukin-1ß或肿瘤坏死因子- 。此外,在三维纤维蛋白基质凝胶试验中,通过CD40诱导的人血管ECs激活通过CD40诱导的管形成,这种作用被MMP抑制剂拮抗了 。这些结果表明,通过与T细胞相互作用而激活EC的 诱导了MMP的合成和释放 ,并通过CD40L-CD40 促进了EC的血管生成功能。信号。由于 在动脉粥样硬化斑块等慢性炎症部位表达CD40及其配体,因此我们的发现表明CD40在EC上的连接可以介导 < / sup> 动脉粥样硬化和其他慢性免疫反应期间血管重塑和新血管形成的方面。

著录项

  • 来源
    《American Journal of Pathology》 |1999年第1期|229-238|共10页
  • 作者单位

    From the Vascular Medicine and Atherosclerosis Unit,* Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and Geneva Biomedical Research Institute, Geneva, Switzerland;

    From the Vascular Medicine and Atherosclerosis Unit,* Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and Geneva Biomedical Research Institute, Geneva, Switzerland;

    From the Vascular Medicine and Atherosclerosis Unit,* Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and Geneva Biomedical Research Institute, Geneva, Switzerland;

    From the Vascular Medicine and Atherosclerosis Unit,* Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and Geneva Biomedical Research Institute, Geneva, Switzerland;

    From the Vascular Medicine and Atherosclerosis Unit,* Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and Geneva Biomedical Research Institute, Geneva, Switzerland;

    From the Vascular Medicine and Atherosclerosis Unit,* Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and Geneva Biomedical Research Institute, Geneva, Switzerland;

    From the Vascular Medicine and Atherosclerosis Unit,* Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and Geneva Biomedical Research Institute, Geneva, Switzerland;

    From the Vascular Medicine and Atherosclerosis Unit,* Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and Geneva Biomedical Research Institute, Geneva, Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号